Citigroup’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10.1M | Buy |
|
|||||
|
2025
Q2 | $4.31M | Sell |
|
|||||
|
2025
Q1 | $5.89M | Buy |
|
|||||
|
2024
Q4 | $4.67M | Buy |
|
|||||
|
2024
Q3 | $3.31M | Buy |
|
|||||
|
2024
Q2 | $728K | Sell |
|
|||||
|
2024
Q1 | $6.04M | Buy |
|
|||||
|
2023
Q4 | $1.67M | Sell |
|
|||||
|
2023
Q3 | $2.47M | Buy |
|
|||||
|
2023
Q2 | $2.97M | Sell |
|
|||||
|
2023
Q1 | $4.42M | Buy |
|
|||||
|
2022
Q4 | $1.62M | Sell |
|
|||||
|
2022
Q3 | $2.66M | Sell |
|
|||||
|
2022
Q2 | $2.51M | Buy |
|
|||||
|
2022
Q1 | $844K | Sell |
|
|||||
|
2021
Q4 | $4.71M | Buy |
|
|||||
|
2021
Q3 | $907K | Sell |
|
|||||
|
2021
Q2 | $3.26M | Sell |
|
|||||
|
2021
Q1 | $2.48M | Buy |
|
|||||
|
2020
Q4 | $196K | Buy |
|
|||||
|
2020
Q3 | $47K | Sell |
|
|||||
|
2020
Q2 | $1.14M | Buy |
|
|||||
|
2020
Q1 | $50K | Buy |
|
|||||
|
2019
Q4 | $40K | Buy |
|
|||||
|
2019
Q3 | $8K | Sell |
|
|||||
|
2019
Q2 | $50K | Sell |
|
|||||
|
2019
Q1 | $319K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $85K | Buy |
|
|||||
|
2018
Q1 | $17K | Buy |
|
|||||
|
2017
Q4 | $36K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $1K | Sell |
|
|||||
|
2017
Q1 | $2K | Sell |
|
|||||
|
2016
Q4 | $168K | Buy |
|
|||||
|
2016
Q3 | $13K | Buy |
|